Peptide Antibiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The peptide antibiotics market is segmented by Product Type (Ribosomal Synthesized Peptide Antibiotics and Non-Ribosomal Synthesized Peptide Antibiotics), Disease (Skin Infection, HABP/VABP, Blood Stream Infection, and Others), Route of Administration (Injectable, Topical, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa , and South America). The report offers the value (in USD million) for the above segments.

Peptide Antibiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Peptide Antibiotics Industry Overview

The peptide antibiotics market is Moderately fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. include Merck & Co., Inc., Monarch Pharmachem, ANI Pharmaceuticals, Inc., Melinta Therapeutics, AbbVie, Cumberland Pharmaceuticals Inc., and Xellia Pharmaceuticals among others.

Peptide Antibiotics Market Leaders

  1. Merck & Co., Inc.

  2. ANI Pharmaceuticals, Inc.

  3. Melinta Therapeutics.

  4. AbbVie

  5. Cumberland Pharmaceuticals Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Screenshot 2022-12-09 132256.png